Risks and Benefits of Janus Kinase Inhibitors in Rheumatoid Arthritis - Past, Present, and Future.

Jasvinder A Singh

Published in: The New England journal of medicine (2022)

Keyphrases

rheumatoid arthritis
disease activity

human health
interstitial lung disease

ankylosing spondylitis
risk assessment

systemic sclerosis
idiopathic pulmonary fibrosis